Viatris (VTRS) EBIT Growth (1y) (2020 - 2026)
Powered by 
Analysis
Viatris (VTRS) EBIT Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | -150.77% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -97.30% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -80.43% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 16.52% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 66.67% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 191.25% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | -5.82% |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | 163.58% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.30% |
| Mar 31, 2026 | 97.23% |
| Dec 31, 2025 | -7.17% |
| Sep 30, 2025 | -20.85% |
| Jun 30, 2025 | 197.12% |
| Mar 31, 2025 | -1,513.54% |
| Dec 31, 2024 | 60.44% |
| Sep 30, 2024 | -49.99% |
| Jun 30, 2024 | -164.98% |
| Mar 31, 2024 | -49.00% |
| Dec 31, 2023 | -125.78% |
| Sep 30, 2023 | -19.35% |
| Jun 30, 2023 | -32.71% |
| Mar 31, 2023 | -43.48% |
| Dec 31, 2022 | -159.41% |
| Sep 30, 2022 | 56.63% |
| Jun 30, 2022 | 1,247.91% |
| Mar 31, 2022 | 365.74% |
| Dec 31, 2021 | 91.19% |
| Sep 30, 2021 | 261.81% |